<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<xs:schema targetNamespace="http://galectintherapeutics.com/20231231" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:galt="http://galectintherapeutics.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="galt-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="galt-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="galt-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="galt-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://galectintherapeutics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConsolidatedStatementsOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" id="ConsolidatedStatementsOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/NatureOfBusinessBasisOfPresentationAndLiquidity" id="NatureOfBusinessBasisOfPresentationAndLiquidity">
        <link:definition>060100 - Disclosure - Nature of Business, Basis of Presentation and Liquidity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>060200 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
        <link:definition>060300 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060400 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConvertibleNotesPayableRelatedParty" id="ConvertibleNotesPayableRelatedParty">
        <link:definition>060500 - Disclosure - Convertible Notes Payable - Related Party</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
        <link:definition>060600 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockholdersEquity" id="StockholdersEquity">
        <link:definition>060700 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/Warrants" id="Warrants">
        <link:definition>060800 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensation" id="StockbasedCompensation">
        <link:definition>060900 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConvertibleLineOfCreditRelatedParty" id="ConvertibleLineOfCreditRelatedParty">
        <link:definition>061000 - Disclosure - Convertible Line of Credit - Related Party</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/LossPerShare" id="LossPerShare">
        <link:definition>061100 - Disclosure - Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>061200 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/GalectinSciencesLlc" id="GalectinSciencesLlc">
        <link:definition>061300 - Disclosure - Galectin Sciences LLC</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>061400 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SubsequentEvent" id="SubsequentEvent">
        <link:definition>061500 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/InsiderTradingArrangements" id="InsiderTradingArrangements">
        <link:definition>061600 - Disclosure - Insider Trading Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>070200 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
        <!--Parent Role: Property and Equipment-->
        <link:definition>080300 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>080400 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>080600 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/WarrantsTables" id="WarrantsTables">
        <!--Parent Role: Warrants-->
        <link:definition>080800 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationTables" id="StockbasedCompensationTables">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>080900 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/LossPerShareTables" id="LossPerShareTables">
        <!--Parent Role: Loss Per Share-->
        <link:definition>081100 - Disclosure - Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>081200 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <!--Parent Role: Income Taxes-->
        <link:definition>081400 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/NatureOfBusinessBasisOfPresentationAndLiquidityDetails" id="NatureOfBusinessBasisOfPresentationAndLiquidityDetails">
        <!--Parent Role: Nature of Business, Basis of Presentation and Liquidity-->
        <link:definition>090100 - Disclosure - Nature of Business, Basis of Presentation and Liquidity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" id="SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>090200 - Disclosure - Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>090202 - Disclosure - Summary of Significant Accounting Policies, Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPoliciesSecurityDepositDetails" id="SummaryOfSignificantAccountingPoliciesSecurityDepositDetails">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>090204 - Disclosure - Summary of Significant Accounting Policies, Security Deposit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPoliciesLonglivedAssetsDetails" id="SummaryOfSignificantAccountingPoliciesLonglivedAssetsDetails">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>090206 - Disclosure - Summary of Significant Accounting Policies, Long-Lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SummaryOfSignificantAccountingPoliciesWarrantsDetails" id="SummaryOfSignificantAccountingPoliciesWarrantsDetails">
        <!--Parent Role: Summary of Significant Accounting Policies-->
        <link:definition>090208 - Disclosure - Summary of Significant Accounting Policies, Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
        <!--Parent Role: Property and Equipment-->
        <link:definition>090300 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>090400 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConvertibleNotesPayableRelatedPartyDetails" id="ConvertibleNotesPayableRelatedPartyDetails">
        <!--Parent Role: Convertible Notes Payable - Related Party-->
        <link:definition>090500 - Disclosure - Convertible Notes Payable - Related Party (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/FairValueOfFinancialInstrumentsAssetsAndLiabilitiesMeasuredAtFairValueDetails" id="FairValueOfFinancialInstrumentsAssetsAndLiabilitiesMeasuredAtFairValueDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090600 - Disclosure - Fair Value of Financial Instruments, Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/FairValueOfFinancialInstrumentsKeyAssumptionsDetails" id="FairValueOfFinancialInstrumentsKeyAssumptionsDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090602 - Disclosure - Fair Value of Financial Instruments, Key Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/FairValueOfFinancialInstrumentsRollForwardOfDerivativeLiabilityDetails" id="FairValueOfFinancialInstrumentsRollForwardOfDerivativeLiabilityDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090604 - Disclosure - Fair Value of Financial Instruments, Roll Forward of Derivative Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockholdersEquityIssuanceOfCommonStockDetails" id="StockholdersEquityIssuanceOfCommonStockDetails">
        <!--Parent Role: Stockholders' Equity-->
        <link:definition>090700 - Disclosure - Stockholders' Equity, Issuance of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockholdersEquitySeries12ConvertiblePreferredStockDetails" id="StockholdersEquitySeries12ConvertiblePreferredStockDetails">
        <!--Parent Role: Stockholders' Equity-->
        <link:definition>090702 - Disclosure - Stockholders' Equity, Series A 12% Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockholdersEquitySeriesC6SuperDividendRedeemableConvertiblePreferredStockDetails" id="StockholdersEquitySeriesC6SuperDividendRedeemableConvertiblePreferredStockDetails">
        <!--Parent Role: Stockholders' Equity-->
        <link:definition>090704 - Disclosure - Stockholders' Equity, Series C 6% Super Dividend Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockholdersEquityReturnOnInvestmentDetails" id="StockholdersEquityReturnOnInvestmentDetails">
        <!--Parent Role: Stockholders' Equity-->
        <link:definition>090706 - Disclosure - Stockholders' Equity, Return on Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/WarrantsSummaryOfWarrantActivityDetails" id="WarrantsSummaryOfWarrantActivityDetails">
        <!--Parent Role: Warrants-->
        <link:definition>090800 - Disclosure - Warrants, Summary of Warrant Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/WarrantsSummaryOfPurchaseWarrantsDetails" id="WarrantsSummaryOfPurchaseWarrantsDetails">
        <!--Parent Role: Warrants-->
        <link:definition>090802 - Disclosure - Warrants, Summary of Purchase Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/WarrantsSummaryOfOutstandingWarrantsIssuedInConnectionWithEquityAndDebtFinancingAndConsultantsDetails" id="WarrantsSummaryOfOutstandingWarrantsIssuedInConnectionWithEquityAndDebtFinancingAndConsultantsDetails">
        <!--Parent Role: Warrants-->
        <link:definition>090804 - Disclosure - Warrants, Summary of Outstanding Warrants Issued in Connection with Equity and Debt Financing and Consultants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationSummaryOfStockbasedCompensationPlansDetails" id="StockbasedCompensationSummaryOfStockbasedCompensationPlansDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090900 - Disclosure - Stock-Based Compensation, Summary of Stock-Based Compensation Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationComponentsOfStockbasedCompensationExpenseDetails" id="StockbasedCompensationComponentsOfStockbasedCompensationExpenseDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090902 - Disclosure - Stock-Based Compensation, Components of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationWeightedAverageAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails" id="StockbasedCompensationWeightedAverageAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090904 - Disclosure - Stock-Based Compensation, Weighted Average Assumptions Used to Determine Fair Value of Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationStockOptionActivityDetails" id="StockbasedCompensationStockOptionActivityDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090906 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationOutstandingAndExercisableOptionsUnderStockBasedCompensationPlansDetails" id="StockbasedCompensationOutstandingAndExercisableOptionsUnderStockBasedCompensationPlansDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090908 - Disclosure - Stock-Based Compensation, Outstanding and Exercisable Options under Stock Based Compensation Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationRestrictedStockIssuancesDetails" id="StockbasedCompensationRestrictedStockIssuancesDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090910 - Disclosure - Stock-Based Compensation, Restricted Stock Issuances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/StockbasedCompensationDeferredStockUnitsDetails" id="StockbasedCompensationDeferredStockUnitsDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>090912 - Disclosure - Stock-Based Compensation, Deferred Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/ConvertibleLineOfCreditRelatedPartyDetails" id="ConvertibleLineOfCreditRelatedPartyDetails">
        <!--Parent Role: Convertible Line of Credit - Related Party-->
        <link:definition>091000 - Disclosure - Convertible Line of Credit - Related Party (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/LossPerShareDetails" id="LossPerShareDetails">
        <!--Parent Role: Loss Per Share-->
        <link:definition>091100 - Disclosure - Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091200 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/CommitmentsAndContingenciesDetailsCalc2" id="CommitmentsAndContingenciesDetailsCalc2">
        <!--Parent Role: Commitments and Contingencies (Details)-->
        <link:definition>091202 - Disclosure - Commitments and Contingencies (Details) Calc 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/GalectinSciencesLlcDetails" id="GalectinSciencesLlcDetails">
        <!--Parent Role: Galectin Sciences LLC-->
        <link:definition>091300 - Disclosure - Galectin Sciences LLC (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/IncomeTaxesComponentsOfNetDeferredTaxAssetsDetails" id="IncomeTaxesComponentsOfNetDeferredTaxAssetsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091400 - Disclosure - Income Taxes, Components of Net Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/IncomeTaxesPrimaryFactorsAffectingIncomeTaxRatesDetails" id="IncomeTaxesPrimaryFactorsAffectingIncomeTaxRatesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091402 - Disclosure - Income Taxes, Primary Factors Affecting Income Tax Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://galectintherapeutics.com/role/SubsequentEventDetails" id="SubsequentEventDetails">
        <!--Parent Role: Subsequent Event-->
        <link:definition>091500 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
  <xs:element name="AccruedResearchAndDevelopmentCostsAndOtherCurrent" id="galt_AccruedResearchAndDevelopmentCostsAndOtherCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="FairValueAdjustmentOfWarrant" id="galt_FairValueAdjustmentOfWarrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ConvertibleNotesPayableRelatedPartyAbstract" id="galt_ConvertibleNotesPayableRelatedPartyAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="QuarterlyInterestRate" id="galt_QuarterlyInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfPromissoryNotesEvidencedByLoansAgreement" id="galt_NumberOfPromissoryNotesEvidencedByLoansAgreement" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfLoansClosing" id="galt_NumberOfLoansClosing" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AnnualInterestRate" id="galt_AnnualInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfPromissoryNotesExecuted" id="galt_NumberOfPromissoryNotesExecuted" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SeptemberConvertiblePromissoryNoteMember" id="galt_SeptemberConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SecondClosingMember" id="galt_SecondClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DecemberConvertiblePromissoryNoteMember" id="galt_DecemberConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FirstClosingMember" id="galt_FirstClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AprilConvertiblePromissoryNoteMember" id="galt_AprilConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClinicalTrialAndResearchContingenciesAbstract" id="galt_ClinicalTrialAndResearchContingenciesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContractCancelationNoticePeriod" id="galt_ContractCancelationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FreeRentPeriod" id="galt_FreeRentPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfOperatingLeases" id="galt_NumberOfOperatingLeases" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SeriesBOneConvertiblePreferredStockMember" id="galt_SeriesBOneConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeriesBTwoConvertiblePreferredStockMember" id="galt_SeriesBTwoConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeriesBThreeConvertiblePreferredStockMember" id="galt_SeriesBThreeConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TwoThousandTwentyMarketAgreementMember" id="galt_TwoThousandTwentyMarketAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommissionRate" id="galt_CommissionRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="UndesignatedCapitalStockSharesAuthorized" id="galt_UndesignatedCapitalStockSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AggregateOfferingPrice" id="galt_AggregateOfferingPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="TwoThousandSeventeenMarketAgreementMember" id="galt_TwoThousandSeventeenMarketAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate" id="galt_PercentageOfWeightedAverageStockPriceForDividendsPriorToPaymentDate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfConsecutiveTradingDays" id="galt_NumberOfConsecutiveTradingDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DividendPaymentScenarioTwoMember" id="galt_DividendPaymentScenarioTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DividendPaymentScenarioOneMember" id="galt_DividendPaymentScenarioOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PostConversionDividendRightsIssued" id="galt_PostConversionDividendRightsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EquityIssuancePerShareAmount" id="galt_EquityIssuancePerShareAmount" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromIssuanceOfPreferredStockNetOfIssuanceCosts" id="galt_ProceedsFromIssuanceOfPreferredStockNetOfIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CommonSharesIssuableUponConversionOfConvertibleStock" id="galt_CommonSharesIssuableUponConversionOfConvertibleStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ClosingDaysAfterConversionRights" id="galt_ClosingDaysAfterConversionRights" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PostConversionRedemptionRightReturnOnInvestmentMultiplierAmount" id="galt_PostConversionRedemptionRightReturnOnInvestmentMultiplierAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ClassOfWarrantOrRightIssued" id="galt_ClassOfWarrantOrRightIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DividendAsPercentageOfNetSales" id="galt_DividendAsPercentageOfNetSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantModificationIncreaseDecreaseInEquityAmount" id="galt_WarrantModificationIncreaseDecreaseInEquityAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="TemporaryEquityDividends" id="galt_TemporaryEquityDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ConvertiblePreferredStockDividends" id="galt_ConvertiblePreferredStockDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ConvertiblePreferredStockDividendsShares" id="galt_ConvertiblePreferredStockDividendsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TemporaryEquityDividendsShares" id="galt_TemporaryEquityDividendsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueWarrantExercise" id="galt_StockIssuedDuringPeriodValueWarrantExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesWarrantExercise" id="galt_StockIssuedDuringPeriodSharesWarrantExercise" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingTermAbstract" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BonusSharesMember" id="galt_BonusSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RestrictedStockGrantsAbstract" id="galt_RestrictedStockGrantsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DeferredCompensationArrangementWithIndividualCashAwardGrantedPaidInDeferredStockUnitsPercent" id="galt_DeferredCompensationArrangementWithIndividualCashAwardGrantedPaidInDeferredStockUnitsPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodOne" id="galt_DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodFive" id="galt_DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodFive" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodThree" id="galt_DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodThree" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodTwo" id="galt_DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodFour" id="galt_DeferredCompensationArrangementPercentageOfDeferredShareUnitsShallBeIssuedPeriodFour" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DeferredCompensationArrangementWithIndividualCashAwardGrantedPaidInCashPercent" id="galt_DeferredCompensationArrangementWithIndividualCashAwardGrantedPaidInCashPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfDirectors" id="galt_NumberOfDirectors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ReclassificationOfAccruedBonusToAdditionalPaidInCapital" id="galt_ReclassificationOfAccruedBonusToAdditionalPaidInCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CommonStockPurchaseWarrantsIssuedInConnectionWithRelatedPartyLineOfCredit" id="galt_CommonStockPurchaseWarrantsIssuedInConnectionWithRelatedPartyLineOfCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ContingentInterestAprilNoteMember" id="galt_ContingentInterestAprilNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContingentInterestSeptemberNoteMember" id="galt_ContingentInterestSeptemberNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContingentInterestDecemberNoteMember" id="galt_ContingentInterestDecemberNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="UndesignatedCapitalStockValue" id="galt_UndesignatedCapitalStockValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BorrowingAndAccruedInterestUnderLineOfCreditNetOfDebtDiscountRelatedPartyNoncurrent" id="galt_BorrowingAndAccruedInterestUnderLineOfCreditNetOfDebtDiscountRelatedPartyNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ConvertibleNotePayableAndAccruedInterestNetOfDebtDiscountRelatedPartyNonCurrent" id="galt_ConvertibleNotePayableAndAccruedInterestNetOfDebtDiscountRelatedPartyNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="UndesignatedCapitalStockSharesDesignated" id="galt_UndesignatedCapitalStockSharesDesignated" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="UndesignatedCapitalStockParValue" id="galt_UndesignatedCapitalStockParValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NatureOfBusinessBasisOfPresentationsAndLiquidityAbstract" id="galt_NatureOfBusinessBasisOfPresentationsAndLiquidityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SupplementalLineOfCreditMember" id="galt_SupplementalLineOfCreditMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WarrantsAbstract" id="galt_WarrantsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonQualifiedOptionsPlansMember" id="galt_NonQualifiedOptionsPlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IncentiveCompensationPlanTwoThousandNineMemberMember" id="galt_IncentiveCompensationPlanTwoThousandNineMemberMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EquityIncentivePlan2019Member" id="galt_EquityIncentivePlan2019Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ComputerAndOfficeEquipmentMember" id="galt_ComputerAndOfficeEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OptionsExercisableAbstract" id="galt_OptionsExercisableAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OptionsOutstandingAbstract" id="galt_OptionsOutstandingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExercisePriceRangeTwoMember" id="galt_ExercisePriceRangeTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExercisePriceRangeFourMember" id="galt_ExercisePriceRangeFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExercisePriceRangeThreeMember" id="galt_ExercisePriceRangeThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExercisePriceRangeFiveMember" id="galt_ExercisePriceRangeFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExercisePriceRangeOneMember" id="galt_ExercisePriceRangeOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CapitalContributionExpense" id="galt_CapitalContributionExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NonCashChargeForResearchAndDevelopmentInProcess" id="galt_NonCashChargeForResearchAndDevelopmentInProcess" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GalectinSciencesLLCMember" id="galt_GalectinSciencesLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SBHSciencesIncMember" id="galt_SBHSciencesIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WarrantTwoMember" id="galt_WarrantTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LineOfCreditRelatedPartyAbstract" id="galt_LineOfCreditRelatedPartyAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DebtInstrumentAccruedInterest" id="galt_DebtInstrumentAccruedInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPercentageEqualToCommonStock" id="galt_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPercentageEqualToCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ClassOfAdditionalWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="galt_ClassOfAdditionalWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantThreeMember" id="galt_WarrantThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IssuanceOfWarrantsValue" id="galt_IssuanceOfWarrantsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="WarrantOneMember" id="galt_WarrantOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="December2022PromissoryNoteMember" id="galt_December2022PromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="March2023PromissoryNoteMember" id="galt_March2023PromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="June2023PromissoryNoteMember" id="galt_June2023PromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SecurityDepositPolicyTextBlock" id="galt_SecurityDepositPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AccruedExpensePolicyTextBlock" id="galt_AccruedExpensePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" id="galt_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ExpiringThrough2037Member" id="galt_ExpiringThrough2037Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OperatingLossCarryforwardsExpirationYear" id="galt_OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FederalAndStateResearchAndDevelopmentCreditsExpirationYear" id="galt_FederalAndStateResearchAndDevelopmentCreditsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ExpiringAsAResultOf2017TaxActMember" id="galt_ExpiringAsAResultOf2017TaxActMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DeferredTaxAssetsValuationAllowancePercentage" id="galt_DeferredTaxAssetsValuationAllowancePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="CommonStockWarrantsDisclosureTextBlock" id="galt_CommonStockWarrantsDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ConvertiblePreferredStockNumberOfVotingRights" id="galt_ConvertiblePreferredStockNumberOfVotingRights" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentageAbstract" id="galt_ReturnOnInvestmentsPercentageAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodSeven" id="galt_ReturnOnInvestmentsPercentagePeriodSeven" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodSix" id="galt_ReturnOnInvestmentsPercentagePeriodSix" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodOne" id="galt_ReturnOnInvestmentsPercentagePeriodOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodThree" id="galt_ReturnOnInvestmentsPercentagePeriodThree" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodEight" id="galt_ReturnOnInvestmentsPercentagePeriodEight" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodTwo" id="galt_ReturnOnInvestmentsPercentagePeriodTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodFive" id="galt_ReturnOnInvestmentsPercentagePeriodFive" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReturnOnInvestmentsPercentagePeriodFour" id="galt_ReturnOnInvestmentsPercentagePeriodFour" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantIssueDate" id="galt_WarrantIssueDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsIssuedPrice" id="galt_WarrantsIssuedPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExpired" id="galt_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExpired" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionTwoMember" id="galt_SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AugustTwelveTwentyZeroNineSeriesBTwoTransactionTwoMember" id="galt_AugustTwelveTwentyZeroNineSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwentyNineTwentySixteenSeriesBThreeTransactionMember" id="galt_SeptemberTwentyNineTwentySixteenSeriesBThreeTransactionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayTenTwentyTenSeriesBTwoTransactionTwoMember" id="galt_MayTenTwentyTenSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DecemberTwentyThreeTwentySixteenSeriesBThreeTransactionMember" id="galt_DecemberTwentyThreeTwentySixteenSeriesBThreeTransactionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TwentyEighteenAndTwentySeventeenWarrantsIssuedForServicesMember" id="galt_TwentyEighteenAndTwentySeventeenWarrantsIssuedForServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DecemberEightTwentyZeroNineSeriesBTwoTransactionTwoMember" id="galt_DecemberEightTwentyZeroNineSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JanuaryTwentyNineTwentyTenSeriesBTwoTransactionTwoMember" id="galt_JanuaryTwentyNineTwentyTenSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayThirteenTwentyZeroNineSeriesBTwoTransactionTwoMember" id="galt_MayThirteenTwentyZeroNineSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NovemberFourTwentyZeroNineSeriesBTwoTransactionTwoMember" id="galt_NovemberFourTwentyZeroNineSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="July222022WarrantsIssuedInConnectionWithRelatedPartyLineOfCreditMember" id="galt_July222022WarrantsIssuedInConnectionWithRelatedPartyLineOfCreditMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JuneThirtyTwentyZeroNineSeriesBTwoTransactionTwoMember" id="galt_JuneThirtyTwentyZeroNineSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FebruaryTwentySevenTwentySeventeenPrivatePlacementMember" id="galt_FebruaryTwentySevenTwentySeventeenPrivatePlacementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember" id="galt_FebruaryTwelveTwentyZeroNineSeriesBOneTransactionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwentyTwoTwentySixteenSeriesBThreeTransactionMember" id="galt_SeptemberTwentyTwoTwentySixteenSeriesBThreeTransactionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AprilThirtyTwentyTenSeriesBTwoTransactionTwoMember" id="galt_AprilThirtyTwentyTenSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MarchEightTwentyTenSeriesBTwoTransactionTwoMember" id="galt_MarchEightTwentyTenSeriesBTwoTransactionTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayTwentyThreeTwentyNinteenRightsOfferingWarrantsMember" id="galt_MayTwentyThreeTwentyNinteenRightsOfferingWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="December292023WarrantsIssuedForDrawOnRelatedPartyLineOfCreditMember" id="galt_December292023WarrantsIssuedForDrawOnRelatedPartyLineOfCreditMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayThirteenTwentyZeroNineSeriesBTwoTransactionOneMember" id="galt_MayThirteenTwentyZeroNineSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JuneThirtyTwentyZeroNineSeriesBTwoTransactionOneMember" id="galt_JuneThirtyTwentyZeroNineSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AugustTwelveTwentyZeroNineSeriesBTwoTransactionOneMember" id="galt_AugustTwelveTwentyZeroNineSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionOneMember" id="galt_SeptemberThirtyTwentyZeroNineSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NovemberFourTwentyZeroNineSeriesBTwoTransactionOneMember" id="galt_NovemberFourTwentyZeroNineSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DecemberEightTwentyZeroNineSeriesBTwoTransactionOneMember" id="galt_DecemberEightTwentyZeroNineSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JanuaryTwentyNineTwentyTenSeriesBTwoTransactionOneMember" id="galt_JanuaryTwentyNineTwentyTenSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MarchEightTwentyTenSeriesBTwoTransactionOneMember" id="galt_MarchEightTwentyTenSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AprilThirtyTwentyTenSeriesBTwoTransactionOneMember" id="galt_AprilThirtyTwentyTenSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayTenTwentyTenSeriesBTwoTransactionOneMember" id="galt_MayTenTwentyTenSeriesBTwoTransactionOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceAbstract" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="galt_ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" id="galt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BeforeModificationMember" id="galt_BeforeModificationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ThresholdPeriodForStockClosingPriceInTenConsecutiveDaysUnderPurchaseWarrantsAgreement" id="galt_ThresholdPeriodForStockClosingPriceInTenConsecutiveDaysUnderPurchaseWarrantsAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BeneficialOwnershipPercentage" id="galt_BeneficialOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ThresholdPeriodForExtensionOfExerciseDateOfPurchaseWarrantsUnderAgreement" id="galt_ThresholdPeriodForExtensionOfExerciseDateOfPurchaseWarrantsUnderAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PeriodOfPriorNoticeThatWouldBarVoluntaryExerciseOfAnyWarrants" id="galt_PeriodOfPriorNoticeThatWouldBarVoluntaryExerciseOfAnyWarrants" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="One0XFundLPMember" id="galt_One0XFundLPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="One0XFundLPAnd10XCapitalManagementLLCMember" id="galt_One0XFundLPAnd10XCapitalManagementLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AfterModificationMember" id="galt_AfterModificationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeriesBWarrantsMember" id="galt_SeriesBWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfTradingDaysToBeConsideredStockClosingPriceInPurchaseAgreement" id="galt_NumberOfTradingDaysToBeConsideredStockClosingPriceInPurchaseAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
</xs:schema>
